International Assets Investment Management LLC Takes $2.16 Million Position in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH)

International Assets Investment Management LLC acquired a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 76,924 shares of the company’s stock, valued at approximately $2,164,000. International Assets Investment Management LLC owned 0.10% of First Trust Nasdaq Pharmaceuticals ETF at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. UBS Group AG raised its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 386.7% during the 4th quarter. UBS Group AG now owns 2,078 shares of the company’s stock valued at $57,000 after purchasing an additional 1,651 shares during the period. NBC Securities Inc. bought a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the 3rd quarter valued at $162,000. NewEdge Advisors LLC increased its holdings in First Trust Nasdaq Pharmaceuticals ETF by 22.1% in the 1st quarter. NewEdge Advisors LLC now owns 7,649 shares of the company’s stock valued at $200,000 after acquiring an additional 1,384 shares during the last quarter. Goldman Sachs Group Inc. bought a new stake in First Trust Nasdaq Pharmaceuticals ETF in the 2nd quarter valued at $216,000. Finally, Susquehanna International Group LLP bought a new stake in First Trust Nasdaq Pharmaceuticals ETF in the 4th quarter valued at $259,000.

First Trust Nasdaq Pharmaceuticals ETF Stock Performance

Shares of NASDAQ FTXH opened at $25.86 on Friday. The company has a market cap of $19.40 million, a P/E ratio of 16.05 and a beta of 0.70. The firm’s fifty day moving average is $27.46 and its two-hundred day moving average is $26.40. First Trust Nasdaq Pharmaceuticals ETF has a 52-week low of $23.85 and a 52-week high of $28.41.

First Trust Nasdaq Pharmaceuticals ETF Announces Dividend

The business also recently declared a dividend, which was paid on Thursday, March 28th. Shareholders of record on Friday, March 22nd were issued a $0.0676 dividend. The ex-dividend date of this dividend was Thursday, March 21st.

First Trust Nasdaq Pharmaceuticals ETF Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.